EyeGene Market Cap

EyeGene has a market cap or net worth of 62.90 billion as of April 29, 2026. Its market cap has decreased by -22.82% in one year.

Market Cap

62.90B

Enterprise Value

17.00B

Revenue

3.57B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,455.00

Market Cap Chart

Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 62.90B, a decrease of -51.99%. That is a compound annual growth rate of -6.78%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	62.90B	-16.33%
Dec 30, 2025	75.18B	8.64%
Dec 30, 2024	69.20B	-24.46%
Dec 28, 2023	91.61B	-15.21%
Dec 29, 2022	108.04B	-73.58%
Dec 30, 2021	408.92B	175.32%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Aptamer Sciences	64.81B
HLB Pep	68.12B
Ark Solutions	68.91B
Psomagen	73.10B
ADBiotech	53.33B
J2KBIO	50.11B
IMGT Co.,Ltd.	78.37B
Progen	79.03B

Market Cap Rankings